Treatment of type 1 immune responsemediated inflammatory lung disease by modulation of IFNgamma activity
Details for Australian Patent Application No. 2004224093 (hide)
International Classifications
Event Publications
13 October 2005 PCT application entered the National Phase
PCT publication WO2004/085477 Priority application(s): WO2004/085477
3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004224094-Unit for applying opening devices to packages of pourable food products
2004224092-Process for preparing crystalline ciclesonide with defined particle size
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser